Meeting
2018 ASCO Annual Meeting
Assessing the difference in efficacy and effectiveness of cancer systemic treatment (tx): A comparison of clinical trial (CT) overall survival (OS) and toxicity data with population-based, real world (RW) OS data.
Authors
Cameron Phillips
University of Toronto, Toronto, ON, Canada
Cameron Phillips , Helen Guo , Deborah Schwartz , Wanrudee Isaranuwatchai , Jaclyn Marie Beca , Wei Fang Dai , Jessica Arias , Scott Gavura , Kelvin K. Chan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research, Clinical Informatics, and Quality of Care
Track
Quality Care/Health Services Research
Sub Track
Outcomes
Citation
J Clin Oncol 36, 2018 (suppl; abstr 6581)
DOI
10.1200/JCO.2018.36.15_suppl.6581
Abstract #
6581
Poster Bd #
406
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Breakthrough
LIBRETTO-432: A phase 3 study of adjuvant selpercatinib or placebo in stage IB-IIIA RET fusion-positive (RET+) NSCLC.
First Author: Theresa Bayt
Poster
2024 ASCO Genitourinary Cancers Symposium
Single-center analysis on a real-world cohort of patients with metastatic urothelial carcinoma studied by NGS: Molecular landscape and efficacy of targeted therapies.
First Author: César Gutiérrez Pérez
Poster
2024 ASCO Genitourinary Cancers Symposium
Enfortumab vedotin treatment regimens and efficacy in urothelial carcinoma: The Mayo Clinic experience.
First Author: Tara Ballouz
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Real-world evaluation of clinical outcomes and long-term survivors in patients with BRAF-V600E metastatic colorectal cancer.
First Author: William Phillips